Challenges Ahead for Specialty Pharmacy

Video

Thomas Cohn, chief strategy officer at Armada Health Care, discusses the biggest challenges specialty pharmacies will face over the next 5 years.

Thomas Cohn, chief strategy officer at Armada Health Care, discusses the biggest challenges specialty pharmacies will face over the next 5 years.

Related Videos
Medical professional researching on a laptop while taking notes
Credit: Adobe Stock - Tierney
https://www.youtube.com/watch?v=Q-WCvWaAcC8
Yaruniv-Studio - stock.adobe.com
Technician- © pharmacytimes
Woman holding a rainbow heart for Pride Month | Image credit: Iuliia Pilipeichenko - stock.adobe.com
Related Content

Artificial Intelligence Is Revolutionizing Controlled Substance Diversion Detection

September 14th 2023

Pharmacy Focus: Psychedelic Pharmacy - Ibogaine Offers Unique Benefits

September 8th 2023

Phase 3 Trial Shows Combined Nivolumab, Ipilimumab Treatment Improved OS in Patients With mNSCLC

September 12th 2023

Pharmacy Focus: Psychedelic Pharmacy - Managing Potential Adverse Effects With Psychedelic Medicines

May 19th 2023

FDA Approves IND for CT7439, a Novel CDK12/13 Inhibitor to Treat Multiple Types of Advanced Solid Tumors

September 11th 2023

Inhibiting PI3K/mTOR, SIRT2 Pathways May Be Effective in Treating Aggressive AML

September 11th 2023

Artificial Intelligence Is Revolutionizing Controlled Substance Diversion Detection

September 14th 2023

Pharmacy Focus: Psychedelic Pharmacy - Ibogaine Offers Unique Benefits

September 8th 2023

Phase 3 Trial Shows Combined Nivolumab, Ipilimumab Treatment Improved OS in Patients With mNSCLC

September 12th 2023

Pharmacy Focus: Psychedelic Pharmacy - Managing Potential Adverse Effects With Psychedelic Medicines

May 19th 2023

FDA Approves IND for CT7439, a Novel CDK12/13 Inhibitor to Treat Multiple Types of Advanced Solid Tumors

September 11th 2023

Inhibiting PI3K/mTOR, SIRT2 Pathways May Be Effective in Treating Aggressive AML

September 11th 2023

Artificial Intelligence Is Revolutionizing Controlled Substance Diversion Detection

September 14th 2023

Pharmacy Focus: Psychedelic Pharmacy - Ibogaine Offers Unique Benefits

September 8th 2023

Phase 3 Trial Shows Combined Nivolumab, Ipilimumab Treatment Improved OS in Patients With mNSCLC

September 12th 2023

Pharmacy Focus: Psychedelic Pharmacy - Managing Potential Adverse Effects With Psychedelic Medicines

May 19th 2023

FDA Approves IND for CT7439, a Novel CDK12/13 Inhibitor to Treat Multiple Types of Advanced Solid Tumors

September 11th 2023

Inhibiting PI3K/mTOR, SIRT2 Pathways May Be Effective in Treating Aggressive AML

September 11th 2023
© 2023 MJH Life Sciences

All rights reserved.